News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
832,523 Results
Type
Article (85683)
Company Profile (650)
Press Release (746190)
Section
Business (232012)
Career Advice (4118)
Deals (39679)
Drug Delivery (120)
Drug Development (90663)
Employer Resources (195)
FDA (17939)
Job Trends (17286)
News (395156)
Policy (39607)
Tag
Academia (2972)
Alliances (56543)
Alzheimer's disease (1383)
Antibody-drug conjugate (ADC) (107)
Approvals (17899)
Artificial intelligence (164)
Bankruptcy (396)
Best Places to Work (12495)
Biotechnology (447)
Breast cancer (175)
Cancer (1430)
Career advice (3520)
CAR-T (120)
Cell therapy (345)
Clinical research (71969)
Collaboration (572)
Compensation (263)
COVID-19 (2802)
C-suite (130)
Data (1293)
Diabetes (140)
Diagnostics (6653)
Earnings (94263)
Employer resources (166)
Events (126983)
Executive appointments (438)
FDA (18569)
Funding (470)
Gene therapy (239)
GLP-1 (676)
Government (5041)
Healthcare (20692)
Infectious disease (2887)
Inflammatory bowel disease (128)
Interviews (808)
IPO (17621)
Job creations (5181)
Job search strategy (2857)
Layoffs (503)
Legal (10029)
Lung cancer (215)
Manufacturing (213)
Medical device (14266)
Medtech (14271)
Mergers & acquisitions (22136)
Metabolic disorders (460)
Neuroscience (1743)
NextGen: Class of 2025 (7658)
Non-profit (5055)
Northern California (1697)
Obesity (257)
Opinion (254)
Patents (119)
People (64388)
Pharmaceutical (132)
Phase I (22222)
Phase II (31277)
Phase III (23533)
Pipeline (570)
Postmarket research (3541)
Preclinical (9985)
Radiopharmaceuticals (245)
Rare diseases (280)
Real estate (7373)
Regulatory (26057)
Research institute (2640)
Resumes & cover letters (649)
Southern California (1471)
Startups (4277)
United States (15267)
Vaccines (648)
Weight loss (201)
Date
Today (135)
Last 7 days (488)
Last 30 days (2108)
Last 365 days (32975)
2025 (2108)
2024 (34084)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57670)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1261)
Arizona (222)
Asia (49478)
Australia (8734)
California (3900)
Canada (1294)
China (348)
Colorado (123)
Connecticut (174)
Europe (113184)
Florida (466)
Georgia (107)
Illinois (383)
Indiana (218)
Maryland (685)
Massachusetts (3184)
Michigan (164)
Minnesota (270)
New Jersey (1105)
New York (1092)
North Carolina (864)
Northern California (1697)
Ohio (132)
Pennsylvania (855)
South America (1646)
Southern California (1471)
Texas (511)
Washington State (430)
832,523 Results for "bird rock bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
Moderna Nabs Another $590M from HHS for mRNA-Based Bird Flu Vaccines
The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready before bird flu strains currently circulating in the wild and on farms can potentially cause human outbreaks.
January 21, 2025
·
1 min read
·
Dan Samorodnitsky
Neurodegenerative disease
Scholar Rock’s Shares Soar 300% After Phase III Win in Spinal Muscular Atrophy
With Monday’s data from SAPPHIRE, Scholar Rock is building toward regulatory submissions for apitegromab in spinal muscular atrophy in the first quarter of 2025.
October 8, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA)
January 29, 2025
·
9 min read
Press Releases
Early-Bird Registration Now Open for the 2025 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit, Presented by BioUtah and the University of Utah Technology Licensing Office March 13-14, 2025
January 9, 2025
·
1 min read
Press Releases
Burning Rock Announces Results of 2024 Annual General Meeting
December 31, 2024
·
1 min read
Press Releases
Scholar Rock Announces the Appointment of Industry Leader Lisa Wyman as Chief Technical and Quality Officer and Planned Leadership Transition
January 29, 2025
·
8 min read
Layoffs
Passage Bio Cutting 55% of Staff to Help Extend Cash Runway
Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues evaluating a treatment for frontotemporal dementia with granulin mutations.
January 13, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Scholar Rock to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 2, 2025
·
2 min read
Business
Burning Rock Reports First Quarter 2024 Financial Results
Burning Rock Biotech Limited, a company focused on the application of next generation sequencing technology in the field of precision oncology, reported financial results for the three months ended March 31, 2024.
May 29, 2024
·
16 min read
Press Releases
Scholar Rock to Participate in Upcoming Investor Conferences
November 1, 2024
·
2 min read
1 of 83,253
Next
